BIT:STLAM
BIT:STLAMAuto

Is Stellantis a Bargain After Recent Electric Vehicle Partnership News?

Wondering if Stellantis is currently a bargain or overpriced? You are not alone, as plenty of investors are watching for the right entry point. The stock has seen some notable movements lately, dipping 0.8% over the past week but actually creeping up by 1.8% in the last month, while still down 31.0% year-to-date. Recent news has swirled around Stellantis’ electric vehicle partnerships and shifting global supply strategies, both believed to be influencing investor sentiment. Industry analysts...
BIT:NEXI
BIT:NEXIDiversified Financial

Does Nexi's (BIT:NEXI) Deal Pause Hint at Shifting Priorities for Payments Growth?

Nexi recently announced it has ended its agreement to acquire Banco Sabadell’s payment subsidiary Paycomet, leaving the door open to future negotiations under revised terms more reflective of today's market conditions. This pause comes amid a broader shift in the European banking and fintech landscape, highlighting increasing deal uncertainty and evolving partnership priorities in payments. We'll examine how Nexi's updated guidance on profit margins and a more cautious management tone after...
BIT:RACE
BIT:RACEAuto

Ferrari (BIT:RACE): Examining Valuation Following Recent Share Price Decline

Ferrari (BIT:RACE) shares have been on the move lately, catching investor interest as the market digests recent performance trends. Many are watching how demand for luxury vehicles, along with broader market dynamics, may influence its valuation. See our latest analysis for Ferrari. After a strong multi-year run, Ferrari’s share price has recently cooled, slipping 14% year-to-date with a 1-year total shareholder return of -15.9%. Still, its impressive 71% total return over three years shows...
BIT:DIA
BIT:DIAMedical Equipment

A Fresh Look at DiaSorin (BIT:DIA)'s Valuation After Mixed Q3 and Nine-Month 2025 Earnings

DiaSorin (BIT:DIA) just released its third quarter and nine-month earnings for 2025, catching investor attention with a mix of lower quarterly figures and higher sales over the longer period compared to last year. See our latest analysis for DiaSorin. DiaSorin’s recent earnings update has added to a challenging stretch for shareholders, with momentum clearly fading as the one-year total shareholder return stands at -45.2% and the share price now sits at $59.22. This reflects investor caution...
BIT:DIA
BIT:DIAMedical Equipment

Do Quarter-to-Quarter Swings Obscure the Long-Term Story for DiaSorin (BIT:DIA)?

DiaSorin S.p.A. recently released its third quarter 2025 earnings, reporting sales of €280 million and net income of €38 million, both showing modest declines compared to the same period last year. While quarterly results were mixed, nine-month sales grew to €900 million, highlighting continued underlying demand despite some profit compression. We'll explore how the combination of slightly lower quarterly earnings and higher nine-month sales could influence DiaSorin's overall growth...
BIT:TEN
BIT:TENEnergy Services

Tenaris (BIT:TEN): Assessing Valuation After Recent Share Price Gains

Tenaris (BIT:TEN) has seen its shares nudge higher recently, catching some attention from investors tracking energy sector moves. After a steady month, questions are popping up about what could drive momentum from this point. See our latest analysis for Tenaris. Tenaris’s 12.8% share price jump over the past month stands out, especially after a quieter start to the year. This momentum contributed to a stronger 1-year total shareholder return of 6.7%, in addition to impressive longer-term...